Conditionally induced RAGE expression by proximal airway epithelial cells in transgenic mice causes lung inflammation

Respiratory Research

Volumn 15, Issue 1, 2014, Pages

  Bodine, B Garrett ^a   Bennion, Brock G ^a   Leatham, Emma ^a   Jimenez, Felix R ^a   Wright, Alex J ^a   Jergensen, Zac R ^a   Erickson, Connor J ^a   Jones, Cameron M ^a   Johnson, Jeff P ^a   Knapp, Steven M ^a   Reynolds, Paul R ^a  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

CCSP; Inflammation; Lung; RAGE; Transgenic

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CELL PROTEIN; CLUB CELL SECRETORY PROTEIN; INTERLEUKIN 14; INTERLEUKIN 7; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; INTERLEUKIN DERIVATIVE; INTERLEUKIN-7, MOUSE; TXLNA PROTEIN, MOUSE; UTEROGLOBIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL STRUCTURE; CELLULAR DISTRIBUTION; CLARA CELL; CONTROLLED STUDY; DISEASE COURSE; EPITHELIUM CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; LUNG HOMOGENATE; LUNG LAVAGE; MOUSE; NEWBORN; NONHUMAN; PNEUMONIA; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; RESPIRATORY EPITHELIUM; STAINING; UPREGULATION; ANIMAL; BRONCHOALVEOLAR LAVAGE FLUID; CHEMISTRY; GENETICS; GENOTYPE; IMMUNOLOGY; LUNG ALVEOLUS CELL; METABOLISM; NEUTROPHIL CHEMOTAXIS; PHENOTYPE; PROMOTER REGION; TRANSGENIC MOUSE;

ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; GENOTYPE; INFLAMMATION MEDIATORS; INTERLEUKIN-7; INTERLEUKINS; MICE, TRANSGENIC; NEUTROPHIL INFILTRATION; PHENOTYPE; PNEUMOCYTES; PNEUMONIA; PROMOTER REGIONS, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; UTEROGLOBIN;

EID: 84978066153     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/s12931-014-0133-y     Document Type: Article

References (46)

1. Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, Avila C, Kambham N, Bierhaus A, Nawroth P: RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell. 1999, 97: 889-901. 10.1016/S0092-8674(00)80801-6.
2. Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, Qu W, Tanji N, Lu Y, Lalla E, Fu C: Blockade of amphoterin/RAGE signalling suppresses tumor growth and metastases. Nature (London). 2000, 405: 354-360. 10.1038/35012626.
3. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Nagashima M, Morser J, Migheli A: RAGE and amyloid beta peptide neurotoxicity in Alzheimer's disease. Nature (London). 1996, 382: 685-691. 10.1038/382685a0.
4. Demling N, Ehrhardt C, Kasper M, Laue M, Knels L, Rieber EP: Promotion of cell adherence and spreading: a novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type I cells. Cell Tissue Res. 2006, 14: 475-488. 10.1007/s00441-005-0069-0.
5. Buckley ST and Ehrhardt C: The receptor for advanced glycation endproducts (RAGE) and the lung.J Biomed Biotechnol 2010, 2010:doi:10.1155/2010/917108,
6. Jemal A, Ward E, Hao Y, Thun M: Trends in the leading causes of death in the United States, 1970-2002. JAMA. 2005, 294 (10): 1255-1259. 10.1001/jama.294.10.1255.
7. Reynolds PR, Kasteler S, Cosio MG, Sturrock A, Huecksteadt TP, Hoidal JR: RAGE: developmental expression and positive feedback regulation by Egr-1 during cigarette smoke exposure in pulmonary epithelial cells. AJP: Lung Cell Mol Physiol. 2008, 294 (6): L1094-L1101.
8. Reynolds PR, Kasteler SD, Schmitt RE, Hoidal JR: RAGE signals through Ras during tobacco smoke-induced pulmonary inflammation. Am J Resp Cell Mol Biol. 2010, 45: 411-418. 10.1165/rcmb.2010-0231OC.
9. Robinson AB, Stogsdill JA, Lewis JP, Wood TA, Reynolds PR: RAGE and tobacco smoke: insights into modeling chronic obstructive pulmonary disease. Frontiers in Resp Physiol. 2012, 3: 301-
10. Robinson AB, Dickson KD, Bennion BG, Reynolds PR: RAGE signaling by alveolar macrophages influences tobacco smoke-induced inflammation. AJP: Lung Cell Mol Physiol. 2012, 302 (11): L1192-L1199.
11. Downward J: Cell cycle: routine role for Ras. Curr Biol. 1997, 7: R258-R260. 10.1016/S0960-9822(06)00116-3.
12. Winston JT, Coats SR, Wang YZ, Pledger WJ: Regulation of the cell cycle machinery by oncogenic ras. Oncogene. 1996, 12: 127-134.
13. Wu L, Ma L, Nicholson LF, Black PN: Advanced glycation end products and its receptor (RAGE) are increased in patients with COPD. Respir Med. 2011, 105 (3): 329-336. 10.1016/j.rmed.2010.11.001.
14. Zhang S, Xu N, Nie J, Dong L, Li J, Tong J: Proteomic alteration in lung disease of rates exposed to cigarette smoke. Toxicol Lett. 2008, 178 (3): 191-196. 10.1016/j.toxlet.2008.03.014.
15. Zhang SP, Wu YW, Wu ZZ, Liu HY, Nie JH, Tong J: Up-regulation of RAGE and S100A6 in rats exposed to cigarette smoke. Environ Toxicol Pharmacol. 2009, 28 (2): 259-264. 10.1016/j.etap.2009.04.013.
16. Ullah MA, Loh Z, Gan WJ, Zhang V, Yang H, Li JH, Yamamoto Y, Schmidt AM, Armour CL, Hughes JM, Phipps S, Sukkar MB: Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation. J Allergy Clin Immunol. 2014, S0091-6749 (13): 02939-4.
17. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. 2007, National Institutes of Health, Bethesda, MD
18. Peters JM, Avol E, Navidi W: A study of twelve Southern California communities with differing levels and types of air pollution: I. Prevalence of respiratory morbidity. Am J Respir Crit Care Med. 1999, 159: 760-767. 10.1164/ajrccm.159.3.9804143.
19. Van der Vaart H, Postma DS: Acute effects of cigarette smoking on inflammation in healthy intermittent smokers. Respir Res. 2005, 6: 22-10.1186/1465-9921-6-22.
20. Boulet L-P, Lemiere C, Archambault F: Smoking and asthma: clinical and radiologic features, lung function, and airwary inflammation. Chest. 2006, 129: 661-668. 10.1378/chest.129.3.661.
21. Maier WC, Arrighi HM, Morray B: Indoor risk factors for asthma and wheezing among Seattle school children. Environ Health Perspect. 1997, 105: 208-214. 10.1289/ehp.97105208.
22. Lam TH, Chung SF, Betson CL: Respiratory symptoms due to active and passive smoking in junior secondary school students in Hong Kong. Int J Epidemiol. 1998, 27: 41-48. 10.1093/ije/27.1.41.
23. Martinez FD, Wright AL, Taussig LM: Asthma and wheezing in the first six years of life. N Engl J Med. 1995, 332: 133-138. 10.1056/NEJM199501193320301.
24. Reynolds PR, Stogsdill JA, Stogsdill MA, Heimann NB: Up-regulation of RAGE by alveolar epithelium influences cytodifferentiation and causes severe lung hypoplasia. Am J Respir Cell Mol Biol. 2011, 45: 1195-1202. 10.1165/rcmb.2011-0170OC.
25. Tichelaar JW, Lu W, Whitsett JA: Conditional expression of fibroblast growth factor-7 in the developing and mature lung. J Biol Chem. 2000, 275 (16): 11858-11864. 10.1074/jbc.275.16.11858.
26. Stogsdill MP, Stogsdill JA, Bodine BG, Fredrickson AC, Sefcik TL, Wood TA, Kasteler SK, Reynolds PR: Conditional RAGE over expression in the adult murine lung causes airspace enlargement and induces inflammation. Am J Resp Cell Mol Biol. 2013, 49 (1): 128-134. 10.1165/rcmb.2013-0013OC.
27. Reynolds PR, Schmitt RE, Kasteler SD, Sturrock A, Sanders K, Bierhaus A, Nawroth PP, Paine R, Hoidal JR: Receptors for advanced glycation end-products targeting protect against hyperoxia-induced lung injury in mice. Am J Respir Cell Mol Biol. 2010, 42 (5): 545-551. 10.1165/rcmb.2008-0265OC.
28. Rao NV, Argyle B, Xu Z, Reynolds PR, Walenga JM, Prechel M, Prestwich GD, Hoidal JR, Kennedy TP: Low anticoagulant heparin targets multiple sites in inflammation, suppresses heparin-induced thrombocytopenia and inhibits interaction of RAGE with its disparate ligands. Am J Physiol Cell Physiol. 2010, 299 (1): C97-C110. 10.1152/ajpcell.00009.2010.
29. Reynolds PR, Wasley KM, Allison CH: Diesel particulate matter induces RAGE expression in pulmonary epithelium and RAGE signaling influences NF-ΚB-mediated inflammation. Environ Health Perspect. 2010, 119 (3): 332-339. 10.1289/ehp.1002520.
30. Reynolds PR, Mucenski ML, Le Cras TD, Nichols WC, Whitsett JA: Midkine is regulated by hypoxia and causes pulmonary vascular remodeling. J Biol Chem. 2004, 279 (35): 37124-37132. 10.1074/jbc.M405254200.
31. Stogsdill JA, Stogsdill MA, Porter JL, Hancock JM, Robinson AB, Reynolds PR: Embryonic overexpression of receptors for advanced glycation end-products by alveolar epithelium induces an imbalance between proliferation and apoptosis. Am J Respir Cell Mol Biol. 2012, 47: 60-66. 10.1165/rcmb.2011-0385OC.
32. Winden DR, Ferguson NT, Bukey BR, Geyer AJ, Wright AJ, Jergensen ZR, Robinson AB, Stogsdill JR, Reynolds PR: Conditional over-expression of RAGE by embryonic alveolar epithelium compromises the respiratory membrane and impairs endothelial cell differentiation. Respir Res. 2013, 14 (1): 108-10.1186/1465-9921-14-108.
33. Perl AK, Kist R, Shan Z, Scherer G, Whitsett JA: Normal lung development and function after Sox9 inactivation in the respiratory epithelium. Genesis. 2005, 41: 23-32. 10.1002/gene.20093.
34. Lee CC, Lai YT, Chang HT, Liao JW, Shyu WC, Li CY, Wang CN: Inhibition of high-mobility group box 1 in lung reduced airway inflammation and remodeling in a mouse model of chronic asthma. Biochem Pharmacol. 2013, 86 (7): 940-949. 10.1016/j.bcp.2013.08.003.
35. Milutinovic PS, Alcorn JF, Englert JM, Crum LT, Oury TD: The receptor for advanced glycation end products is a central mediator of asthma pathogenesis. Am J Pathol. 2012, 181 (4): 1215-1225. 10.1016/j.ajpath.2012.06.031.
36. Zhou Y, Jiang YQ, Wang WX, Zhou ZX, Wang YG, Yang L, Ji YL: HMGB1 and RAGE levels in induced sputum correlate with asthma severity and neutrophil percentage. Hum Immunol. 2012, 73 (11): 1171-1174. 10.1016/j.humimm.2012.08.016.
37. Clarke DL, Davis NH, Majithiya JB, Piper SC, Lewis A, Sleeman MA, Corkill DJ, May RD: Development of a mouse model mimicking key aspects of a viral asthma exacerbation. Clin Sci (Lond). 2014, 126 (8): 567-580. 10.1042/CS20130149.
38. Idriss HT, Naismith JH: TNF alpha and the TNF receptor superfamily: structure-function relationship(s). Microsc Res Tech. 2000, 50 (3): 184-195. 10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H.
39. Alek-Ardakani S, Croft M: Tumor necrosis factor receptor/tumor necrosis factor family members in antiviral CD8 T-cell immunity. J Interferon Cytokine Res. 2010, 30 (4): 205-218. 10.1089/jir.2010.0026.
40. Zelová H, Hošek J: TNF-α signaling and inflammation: interactions between old acquaintances. Inflamm Res. 2013, 62 (7): 641-651. 10.1007/s00011-013-0633-0.
41. Namen AE, Schmierer AE, March CJ, Overell RW, Park LS, Urdal DL, Mochizuki DY: B cell precursor growth-promoting activity. Purification and characterization of a growth factor active on lymphocyte precursors. J Exp Med. 1988, 167 (3): 988-1002. 10.1084/jem.167.3.988.
42. Appasamy PM: Interleukin-7: biology and potential clinical applications. Cancer Invest. 1993, 11 (4): 487-499. 10.3109/07357909309018880.
43. Thomas PS, Heywood G: Effects of inhaled tumour necrosis factor alpha in subjects with mild asthma. Thorax. 2002, 57 (9): 774-778. 10.1136/thorax.57.9.774.
44. Fuentes-Mattei E, Rivera E, Gioda A, Sanchez-Rivera D, Roman-Velazquez FR, Jimenez-Velez BD: Use of human bronchial epithelial cells (BEAS-2B) to study immunological markers resulting from exposure to PM(2.5) organic extract from Puerto Rico. Toxicol Appl Pharmacol. 2010, 243 (3): 381-389. 10.1016/j.taap.2009.12.009.
45. Matías V, San Feliciano L, Fernández JE, Lapeña S, Garrido E, Ardura J, Soga MJ, Aragón MP, Remesal A, Benito F, Andrés J, Centeno F, Marugán V, Bachiller R, Bermejo-Martin JF: Host and environmental factors influencing respiratory secretion of pro-wheezing biomarkers in preterm children. Pediatr Allergy Immunol. 2012, 23 (5): 441-447. 10.1111/j.1399-3038.2012.01269.x.
46. Zhao YL, Duanmu HJ, Li L, Song CX, Zhao B: Study of the expression profile of immunogenesis associated genes in tuberculosis by microarray. Zhonghua Jie He He Hu Xi Za Zhi. 2005, 28 (5): 301-304.